Scienti˜c Program - WOC2012

Scientific Program
Saturday, 18 February 2012
IS-WFS-SA 166
Sat 18 Feb 08:30 - 10:00 Conference Room B3
Novel Control Strategies for Diabetic
Retinopathy
Chairpersons: Nathan Congdon, Ciku Mathenge
08:30 The Role of "RAAB+DR" Surveys in Planning for DR
Programs, David Yorston
08:40 Screening of Diabetic Retinopathy: The Tailored
Approach, Edoardo Midena
08:50 Video Recording: A New Way to Perform Telemedicine
Based Screening of Diabetic Retinopathy,
Yogesan Kanagasingam
09:00 The Realities of Diabetic Retinopathy in an African
Population, Ciku Mathenge
09:10 Key Research Questions in Delivering DR Care in Areas
of Limited Resources, Nathan Congdon
09:20 Panel Discussion
09:40 Q&A Session
IS-SOS-SA 167
Sat 18 Feb 08:30 - 10:00 Capital Suite 1
General Refraction
Organized by the Saudi Ophthalmological Society (SOS)
Chairpersons: Adwa Al Oqiel, Angela Malik, Shrikant Bharadwaj
08:30 How Anisometropia of Various Forms Impact Visual
Function, Shrikant Bharadwaj
08:45 Correcting with Bifocals,Trifocals and Multifocals,
William Ehlers
08:55 Epidemiology of Refractive Errors and Presbyopia,
Srinivas Marmamula
09:10 New Innovations in Optometry, Angela Malik
09:20 Refractive Techniques for Special Needs Patients,
William Ehlers
09:30 Dynamic Retinoscopy: Techniques, Applications and its
Significance, Sarah Al Ohali
09:40 Q&A Session
IS-EVI-SA 168
Sat 18 Feb 08:30 - 10:00 Capital Suite 7
Avastin and Ranibizumab for Treatment
of Age-Related Macular Degeneration:
Where is the Evidence
Chairpersons: Tien Yin Wong, Timothy Lai
08:30 Efficacy of Avastin Versus Lucentis for Management of
Wet AMD - Implications of the CATT and Other Trials,
Paul Mitchell
08:40 Are There Real Differences in Safety Between Avastin and
Lucentis, Mark Gillies
08:50 Avastin and Ranibizumab for Treatment of AMD: How to
Present the Evidence Ethically Manal Bouhaimed
09:00 Summary of Evidence on Avastin and Lucentis for
Management of Diabetic Macular Edema, Tien Yin
Wong
09:10 Management of PCV - Is There a Difference
Between Anti-VEGF Agents, Timothy Lai
09:20 Panel Discussion
09:40 Q&A Session
IS-PHA-SA 169
Sat 18 Feb 08:30 - 10:00 Capital Suite 5
Ocular Drug Delivery
Chairpersons: Jose Cardillo, Mark Humayun, Albert
Augustin
08:30 Steroid Implants (Ozurdex, Iluvien, Retisert),
Baruch Kuppermann
08:40 Cell Based Drug Delivery Systems, Weng Tao
08:50 Microspheres and Lipid Emulsions, Jose Cardillo
09:00 Topical Therapy for Posterior Segment Diseases,
Einar Stefansson
09:10 Bioelectronics in Ophthalmology: External
Reservoir Implant for Ocular Drug Delivery,
Mark Humayun
09:20 Panel Discussion
09:40 Q&A Session
IS-IMG-SA 170
Sat 18 Feb 08:30 - 10:00 Conference Room B1
Presence and Future of Imaging in
Glaucoma
Chairpersons: Leopold Schmetterer
08:30 Comparison Between GDX, HRT and OCT,
Carlo Traverso
08:40 Structural Functional Relationships in Glaucoma,
Gerhard Garhöfer
08:50 The Future of Imaging in Glaucoma,
Leopold Schmetterer
09:00 The Value of Imaging in Clinical Praxis,
Anton Hommer
09:10 Panel Discussion
09:35 Q&A Session
FP-PED-SA 171
Sat 18 Feb 08:30 - 10:00 Capital Suite 13
Free Paper: Pediatric Ophthalmology,
Genetics
Chairpersons: Sumit Monga, Parikshit Gogate
08:30 Simultaneous Bilateral Surgery in Congenital Cataract,
Renuka Srinivasan
08:37 Secondary Intraocular Lens Implantation in Children:
A Decade Long Analysis of Safety and Refractive
Outcomes, Sumit Monga
08:44 Traumatic Pediatric Cataract in Central India: Etiology,
Visual Outcomes and Prognostic Treatment Variables,
Anupam Sahu
58